TP53 and breast neoplasm: The addition of PTX into the composition of the GF and GFAP scaffolds determined the notable increase in p53, NLRP3, and caspase-1 protein expression in the MDA-MB-231 cells, suggesting the activation of pyroptosis cell death associated with NLRP3 inflammasome assembly as a consequence of PTX treatment of breast tumor cells.